SIPC Stock Overview
Engages in the manufacture and sale of generic medicines in Egypt. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Sabaa International Company for Pharmaceutical and Chemical Industry Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ج.م1.46 |
| 52 Week High | ج.م1.85 |
| 52 Week Low | ج.م0.61 |
| Beta | 0.77 |
| 11 Month Change | 19.67% |
| 3 Month Change | 86.94% |
| 1 Year Change | 78.70% |
| 33 Year Change | 38.00% |
| 5 Year Change | 232.65% |
| Change since IPO | 73.86% |
Recent News & Updates
Recent updates
Shareholder Returns
| SIPC | EG Pharmaceuticals | EG Market | |
|---|---|---|---|
| 7D | -2.7% | -2.7% | -1.6% |
| 1Y | 78.7% | 25.3% | 26.5% |
Return vs Industry: SIPC exceeded the EG Pharmaceuticals industry which returned 28.5% over the past year.
Return vs Market: SIPC exceeded the EG Market which returned 27.8% over the past year.
Price Volatility
| SIPC volatility | |
|---|---|
| SIPC Average Weekly Movement | 14.5% |
| Pharmaceuticals Industry Average Movement | 6.4% |
| Market Average Movement | 5.4% |
| 10% most volatile stocks in EG Market | 9.8% |
| 10% least volatile stocks in EG Market | 3.8% |
Stable Share Price: SIPC's share price has been volatile over the past 3 months compared to the EG market.
Volatility Over Time: SIPC's weekly volatility has increased from 9% to 14% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | 165 | Sahal Morsi Al-Damrawi | www.sabaapharmagroup.com |
Sabaa International Company for Pharmaceutical and Chemical Industry engages in the manufacture and sale of generic medicines in Egypt. It offers hard gelatin capsules, such as Acitretin; film coated tablets, including Saboctic, Topiramate, and Tolterodine; and tablets, such as Claudol and Flamogen E.C.T. The company also provides OTCs, food supplements, and veterinary products, as well as medicine trials services.
Sabaa International Company for Pharmaceutical and Chemical Industry Fundamentals Summary
| SIPC fundamental statistics | |
|---|---|
| Market cap | ج.م365.00m |
| Earnings (TTM) | -ج.م8.61m |
| Revenue (TTM) | ج.م15.56m |
23.5x
P/S Ratio-42.4x
P/E RatioIs SIPC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SIPC income statement (TTM) | |
|---|---|
| Revenue | ج.م15.56m |
| Cost of Revenue | ج.م10.08m |
| Gross Profit | ج.م5.48m |
| Other Expenses | ج.م14.08m |
| Earnings | -ج.م8.61m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.034 |
| Gross Margin | 35.22% |
| Net Profit Margin | -55.30% |
| Debt/Equity Ratio | 19.1% |
How did SIPC perform over the long term?
See historical performance and comparison